11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nanomedicine: Past, present and future - A global perspective.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanomedicine is an emerging and rapidly evolving field and includes the use of nanoparticles for diagnosis and therapy of a variety of diseases, as well as in regenerative medicine. In this mini-review, leaders in the field from around the globe provide a personal perspective on the development of nanomedicine. The focus lies on the translation from research to development and the innovation supply chain, as well as the current status of nanomedicine in industry. The role of academic professional societies and the importance of government funding are discussed. Nanomedicine to combat infectious diseases of poverty is highlighted along with other pertinent examples of recent breakthroughs in nanomedicine. Taken together, this review provides a unique and global perspective on the emerging field of nanomedicine.

          Related collections

          Author and article information

          Journal
          Biochem. Biophys. Res. Commun.
          Biochemical and biophysical research communications
          1090-2104
          0006-291X
          Dec 18 2015
          : 468
          : 3
          Affiliations
          [1 ] Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington D.C., USA. Electronic address: change@georgetown.edu.
          [2 ] SynerGene Therapeutics, Inc., Potomac, MD, USA.
          [3 ] European Technology Platform on Nanomedicine, c/o VDI/VDE Innovation + Technik GmbH, Berlin, Germany.
          [4 ] CSIR Materials Science and Manufacturing, Polymers & Composites, Pretoria, South Africa.
          [5 ] Department of Nuclear Medicine, Department of Molecular Medicine and Pharmaceutical Sciences, Seoul National University, Seoul, South Korea.
          Article
          S0006-291X(15)01239-5
          10.1016/j.bbrc.2015.10.136
          26518648
          22420158-f485-47c0-9a8e-d3abff73786b
          Copyright © 2015. Published by Elsevier Inc.
          History

          Diagnostics,Drug delivery,Funding,Imaging,Innovation,Nanomedicine

          Comments

          Comment on this article